Back

Diurnal variability of on-treatment platelet reactivity in clopidogrel vs. prasugrel treated acute coronary syndrome patients: a pre-specified TROPICAL-ACS sub-study

28 August 2018 (14:51 - 15:02)
Organised by:
Congress Presentation Part of: The role of platelet function in acute coronary syndromes Pharmacotherapy ESC Premium Access ESC Congress 2018

About the speaker

Photo
Doctor Ralph Hein

Clinic Dritter Orden, Munich (Germany)

4 More presentations in this session

Presentation thumbnail
De-escalation versus escalation of antiplatelet therapy in elderly ACS patients: insight from the ANTARCTIC trial.
Professor G. Cayla (Nimes, FR)
Abstract Slides Video
Presentation thumbnail
Platelet function testing predicts bleeding complications in elderly patients admitted for an acute coronary syndrome: insights from the ANTARCTIC trial
Doctor B. Lattuca (Nimes, FR)
Abstract Slides Video
Presentation thumbnail
Comparison of platelet inhibition in patients with ST-elevation myocardial infarction vs. non-ST elevation myocardial infarction after a loading dose of swallowed vs. chewed ticagrelor.
Professor S. Matetzky (Ramat Gan, IL)
Abstract
Presentation thumbnail
Influence of intravenous fentanyl versus morphine on ticagrelor absorption and platelet inhibition in patients with ST-segment elevation myocardial infarction undergoing primary PCI
Doctor J. Iglesias (Geneva, CH)
Abstract Slides Video

Access the full session

Session thumbnail
The role of platelet function in acute coronary syndromes

The Event

Event poster

ESC Congress 2018

28 August 2018 14:51 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources